Month: April 2020

COVID-19 Vaccine trials activity has been very high in recent weeks; most products are still at the preclinical stage, but there are already phase I and phase II trials ongoing, most of them from China. Regarding drug clinical trials, our update gives a good picture of today’s research activity by geographical region.

The number of interventional trials is still rising, with now 30 trials that will include more than 1,000 patients each. The most tested drugs remain Hydoxychloroquine and antivirals.
We also provide insights on the modes of action of the different drugs tested, thanks to a James M. Sanders et al.

The number of COVID-19 clinical trials is continually growing, with Europe and the US now in the driver’s seat. here is our second weekly newsletter, with a special focus on the most studied drug so far, hydroxychloroquine.
Copyright CEPTON and INATO

Following the spectacular growth of the pandemic, numerous clinical trials have been initiated throughout the world in the past few weeks. CEPTON and INATO will present you an overview of these trials, updated on a regular basis. Here is the current status, based on the  ANTICOVID  data.